Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$988.9K
31.99K shares
What this filing means
GHEUENS SARAH plans to sell 31.99K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $988.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/22/2026ACC: 0001950047-26-010371
Officer· Chief Medical Officer
Since Sep 2021
31.99K
Shares to sell
$988.9K
Approx. market value
500.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/22/2026
500.00Total acquired500.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/22/2026 | Stock Option Exercise Cash | 500.00 | — |
| Total | 500.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.49K
Market value
$55.9K
10/21/2026
—Completed
Units to sell
30K
Market value
$914.3K
8/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
500.00
Market value
$18.8K
10/22/2026
Total
Units
31.99K
Value
$988.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/21/2026 | 1.49K | $55.9K | — | Completed |
8/4/2026 | 30K | $914.3K | — | Completed |
| Planned — Approximate Date | ||||
10/22/2026 | 500.00 | $18.8K | NASDAQ | Planned |
| Total | 31.99K | $988.9K | ||